Literature DB >> 24382278

Metabolic syndrome in psoriatic arthritis patients: a cross-sectional study.

Aman Sharma1, Dharmesh Gopalakrishnan, Ramesh Kumar, Rajesh Vijayvergiya, Sunil Dogra.   

Abstract

OBJECTIVES: The major objective of our study was to assess the prevalence of metabolic syndrome in Indian patients with psoriatic arthritis.
METHOD: This was a one-time survey involving no follow-up. The study was performed among outpatients attending the speciality clinics of an institutional tertiary referral centre. A consecutive sample of 100 patients diagnosed as having psoriatic arthritis in our clinics was included in the study. Height, weight, body mass index, blood pressure and waist circumference of patients were measured at the enrolment visit. Venous samples were taken after 8 h of overnight fasting for the estimation of serum cholesterol, triglycerides and plasma glucose levels. The primary study outcome was the prevalence of metabolic syndrome in the study population.
RESULTS: Fifty-eight and 59 patients had metabolic syndrome according to the Adult Treatment Panel III criteria and the consensus definition of metabolic syndrome for adult Asian patients, respectively. Patients with metabolic syndrome were older (P < 0.001), with longer duration of psoriasis (P = 0.017), and higher Bath Ankylosing Spondylitis Activity Index (P = 0.016) than those without metabolic syndrome.
CONCLUSIONS: Metabolic syndrome is common in Asian Indian patients with psoriatic arthritis, especially in those with long-standing psoriasis and active joint disease.
© 2013 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  clinical aspects; metabolic syndrome; psoriatic arthritis

Mesh:

Year:  2013        PMID: 24382278     DOI: 10.1111/1756-185X.12134

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  10 in total

Review 1.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

2.  Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?

Authors:  Özlem Özkul; Ayten Yazıcı; Aysun S Aktürk; Duygu T Karadağ; Özlem O Işık; Senem Tekeoğlu; Ayşe Cefle
Journal:  Eur J Rheumatol       Date:  2018-10-01

3.  Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis.

Authors:  April W Armstrong; Julie Wu; Mary Ann Johnson; Dmitry Grapov; Baktazh Azizi; Jaskaran Dhillon; Oliver Fiehn
Journal:  F1000Res       Date:  2014-10-21

4.  Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring.

Authors:  Sunil Dogra; Rahul Mahajan
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

5.  Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors.

Authors:  Kumari Asha; Archana Singal; Suman Bala Sharma; Vinod Kumar Arora; Amitesh Aggarwal
Journal:  Indian J Med Res       Date:  2017-12       Impact factor: 2.375

6.  Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study.

Authors:  Premarani Sinnathurai; Alexandra Capon; Rachelle Buchbinder; Vibhasha Chand; Lyndall Henderson; Marissa Lassere; Lyn March
Journal:  BMC Rheumatol       Date:  2018-09-06

7.  Higher bodily adiposity, fat intake, and cholesterol serum levels are associated with higher disease activity in psoriatic arthritis patients: is there a link among fat and skin and joint involvement?

Authors:  Beatriz Figueiredo Leite; Melissa Aparecida Morimoto; Carina Gomes; Barbara Nascimento de Carvalho Klemz; Patrícia de Souza Genaro; Nágila Raquel Teixeira Damasceno; Vera Lúcia Szejnfeld; Marcelo de Medeiros Pinheiro
Journal:  Lipids Health Dis       Date:  2020-02-07       Impact factor: 3.876

8.  Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study.

Authors:  Chonachan Petcharat; Varalak Srinonprasert; Praveena Chiowchanwisawakit
Journal:  BMC Musculoskelet Disord       Date:  2021-04-20       Impact factor: 2.362

9.  Detection of subclinical skin manifestation in patients with psoriasis and psoriatic arthritis by fluorescence optical imaging.

Authors:  A Schmidt; A M Glimm; I K Haugen; P Hoff; G Schmittat; G R Burmester; J Klotsche; S Ohrndorf
Journal:  Arthritis Res Ther       Date:  2020-08-18       Impact factor: 5.156

10.  Dyslipidemia Might Be Associated with an Increased Risk of Osteoarthritis.

Authors:  Jianping Xiong; Junyu Long; Xi Chen; Ye Li; Hai Song
Journal:  Biomed Res Int       Date:  2020-02-15       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.